Cargando…
Clinical significance of pancreatic calcifications: a 15-year single-center observational study
OBJECTIVES: Pancreatic calcifications (PC) are considered specific for chronic pancreatitis (CP), but PC may also be present in non-CP diseases. The aims are to understand the pattern of calcifications in different diseases and to determine they were related to malignant diseases. METHODS: A retrosp...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233388/ https://www.ncbi.nlm.nih.gov/pubmed/35752857 http://dx.doi.org/10.1186/s40001-022-00725-9 |
_version_ | 1784735754734272512 |
---|---|
author | Wang, Wei Chai, Li Zhu, Naiyi Wang, Qingrou Zhou, Yiran Chai, Weimin |
author_facet | Wang, Wei Chai, Li Zhu, Naiyi Wang, Qingrou Zhou, Yiran Chai, Weimin |
author_sort | Wang, Wei |
collection | PubMed |
description | OBJECTIVES: Pancreatic calcifications (PC) are considered specific for chronic pancreatitis (CP), but PC may also be present in non-CP diseases. The aims are to understand the pattern of calcifications in different diseases and to determine they were related to malignant diseases. METHODS: A retrospective study was performed including patients with PC or CP undergoing surgery in the Department of General Surgery of Ruijin Hospital from January 2003 to June 2018. RESULTS: PC were observed in 168 (4.5%) of the 3755 patients with pancreatic lesions treated during the study period. The majority of patients with PC had three kinds of CP (73.2%) while 26.8% had other five kinds of non-CP diseases. In patients with non-CP diseases, the incidence of PC in malignant intraductal papillary mucinous neoplasm (IPMN) was significantly higher than benign IPMN (8.3% vs. 0.7%, p = 0.004). In patients of CP with pancreatic mass (n = 81), PC (Odds ratio = 28.6, p = 0.000), advanced age (> 55 years) and parenchymal atrophy were independent predictors for malignancy. In patients of CP without pancreatic mass (n = 110), there were 82 cases (74.5%) with PC and 5 cases (4.5%) with pancreatic ductal adenocarcinoma. The regression model of risk factors was not successful. CONCLUSIONS: The disease spectrum with PC was very diverse. PC may be related to malignant IPMN in non-CP diseases and is related to malignancy in the patients of CP with pancreatic mass and indications for resection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40001-022-00725-9. |
format | Online Article Text |
id | pubmed-9233388 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92333882022-06-26 Clinical significance of pancreatic calcifications: a 15-year single-center observational study Wang, Wei Chai, Li Zhu, Naiyi Wang, Qingrou Zhou, Yiran Chai, Weimin Eur J Med Res Research OBJECTIVES: Pancreatic calcifications (PC) are considered specific for chronic pancreatitis (CP), but PC may also be present in non-CP diseases. The aims are to understand the pattern of calcifications in different diseases and to determine they were related to malignant diseases. METHODS: A retrospective study was performed including patients with PC or CP undergoing surgery in the Department of General Surgery of Ruijin Hospital from January 2003 to June 2018. RESULTS: PC were observed in 168 (4.5%) of the 3755 patients with pancreatic lesions treated during the study period. The majority of patients with PC had three kinds of CP (73.2%) while 26.8% had other five kinds of non-CP diseases. In patients with non-CP diseases, the incidence of PC in malignant intraductal papillary mucinous neoplasm (IPMN) was significantly higher than benign IPMN (8.3% vs. 0.7%, p = 0.004). In patients of CP with pancreatic mass (n = 81), PC (Odds ratio = 28.6, p = 0.000), advanced age (> 55 years) and parenchymal atrophy were independent predictors for malignancy. In patients of CP without pancreatic mass (n = 110), there were 82 cases (74.5%) with PC and 5 cases (4.5%) with pancreatic ductal adenocarcinoma. The regression model of risk factors was not successful. CONCLUSIONS: The disease spectrum with PC was very diverse. PC may be related to malignant IPMN in non-CP diseases and is related to malignancy in the patients of CP with pancreatic mass and indications for resection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40001-022-00725-9. BioMed Central 2022-06-25 /pmc/articles/PMC9233388/ /pubmed/35752857 http://dx.doi.org/10.1186/s40001-022-00725-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Wei Chai, Li Zhu, Naiyi Wang, Qingrou Zhou, Yiran Chai, Weimin Clinical significance of pancreatic calcifications: a 15-year single-center observational study |
title | Clinical significance of pancreatic calcifications: a 15-year single-center observational study |
title_full | Clinical significance of pancreatic calcifications: a 15-year single-center observational study |
title_fullStr | Clinical significance of pancreatic calcifications: a 15-year single-center observational study |
title_full_unstemmed | Clinical significance of pancreatic calcifications: a 15-year single-center observational study |
title_short | Clinical significance of pancreatic calcifications: a 15-year single-center observational study |
title_sort | clinical significance of pancreatic calcifications: a 15-year single-center observational study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233388/ https://www.ncbi.nlm.nih.gov/pubmed/35752857 http://dx.doi.org/10.1186/s40001-022-00725-9 |
work_keys_str_mv | AT wangwei clinicalsignificanceofpancreaticcalcificationsa15yearsinglecenterobservationalstudy AT chaili clinicalsignificanceofpancreaticcalcificationsa15yearsinglecenterobservationalstudy AT zhunaiyi clinicalsignificanceofpancreaticcalcificationsa15yearsinglecenterobservationalstudy AT wangqingrou clinicalsignificanceofpancreaticcalcificationsa15yearsinglecenterobservationalstudy AT zhouyiran clinicalsignificanceofpancreaticcalcificationsa15yearsinglecenterobservationalstudy AT chaiweimin clinicalsignificanceofpancreaticcalcificationsa15yearsinglecenterobservationalstudy |